# US 2010/0144551 A1 · Cytokine production regulator gene and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0144551 A1
- Document ID: US20100144551A1
- Status: Published application
- Kind: A1
- Application number: 12/447,370
- Filed: 2007-10-26
- Published: 2010-06-10
- Earliest claimed: 2006-10-27
- Assignees: Kabushiki Kaisha Yakult Honsha
- Inventors: Tomoyuki Sako; Emi Yasuda; Masaki Serata; Satoshi Matsumoto; Kan Shida
- Web page: https://patentgrep.com/patent/US20100144551A1

## CPC

- C12N 15/52: Genes encoding for enzymes or proenzymes
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 17/00: Drugs for dermatological disorders
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/04: Antibacterial agents
- A61P 31/12: Antivirals
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 37/02: Immunomodulators
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 9/1048: {Glycosyltransferases (2.4)}
- C12P 19/04: Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention provides a gene encoding a protein selected from among the following proteins (a) to (c): (a) a protein having any of the amino acid sequences of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, and 108; (b) a protein which has an amino acid sequence equivalent to any of the amino acid sequences of (a), except that one to several amino acid residues are deleted, substituted, or added, and which exhibits cytokine production regulatory activity; and (c) a protein which has an amino acid sequence having 90% or higher identity to any of the amino acid sequences of (a), and which exhibits cytokine production regulatory activity, as well as a gene useful for regulating cytokine production and use of the gene.

## Claims

### Claim 1

A gene encoding a protein selected from among the following proteins (a) to (c):
(a) a protein having any of the amino acid sequences of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, and 108;
(b) a protein which has an amino acid sequence equivalent to any of the amino acid sequences of (a), except that one to several amino acid residues are deleted, substituted, or added, and which exhibits cytokine production regulatory activity; and
(c) a protein which has an amino acid sequence having 90% or higher identity to any of the amino acid sequences of (a), and which exhibits cytokine production regulatory activity.

### Claim 2

A gene having a polynucleotide selected from among the following polynucleotides (d) to (f):
(d) a polynucleotide having any of the nucleotide sequences of SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, and 107;
(e) a polynucleotide which hybridizes, under stringent conditions, with a polynucleotide having a nucleotide sequence complementary to any of the nucleotide sequences of (d), and which encodes a protein exhibiting cytokine production regulatory activity; and
(f) a polynucleotide which has a nucleotide sequence having 90% or higher identity to any of the nucleotide sequences of (d), and which encodes a protein exhibiting cytokine production regulatory activity.

### Claim 3 (depends on 1, 2)

A method for regulating cytokine production in a microorganism, comprising introducing the gene as recited in claim 1 or 2 into the microorganism, or modifying the gene present in the microorganism.

### Claim 4 (depends on 3)

The method as described in claim 3, wherein gene modification is inhibition, suppression, or promotion of expression of the gene.

### Claim 5 (depends on 1, 2)

A microorganism in which the gene as recited in claim 1 or 2 has been introduced or modified.

### Claim 6 (depends on 5)

The microorganism as described in claim 5, which is a Gram-positive bacterium.

### Claim 7 (depends on 6)

The microorganism as described in claim 6, wherein the Gram-positive bacterium is a bacterium belonging to the genus Lactobacillus.

### Claim 8 (depends on 7)

The microorganism as described in claim 7, wherein the bacterium belonging to the genus Lactobacillus is Lactobacillus casei.

### Claim 9 (depends on 5)

A food or beverage containing the microorganism as recited in claim 5.

### Claim 10 (depends on 5)

A drug containing the microorganism as recited in claim 5.

### Claim 11 (depends on 1, 2)

A method for screening a microorganism exhibiting cytokine production regulatory activity, comprising determining the presence or absence of the gene as recited in claim 1 or 2, and/or determining the level of expression of the gene.

### Claim 12 (depends on 2)

A recombinant vector containing any of the polynucleotides as recited in claim 2 or a portion thereof.

### Claim 13 (depends on 12)

A host microorganism containing a recombinant vector as recited in claim 12.

### Claim 14 (depends on 2)

A nucleic acid fragment which specifically hybridizes with any of the polynucleotides as recited in claim 2.

### Claim 15 (depends on 2)

A DNA array or DNA chip containing any of the polynucleotides as recited in claim 2 or a portion thereof.
